Coherus Oncology, Inc.
CHRS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001512762
No open-market purchases or sales by Coherus Oncology, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Coherus Oncology, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 161 | 1 | 163 | +3 |
| Shares | 78.6M | 37.9K | 78.4M | −159.9K (−0.2%) |
| Value | $622.7M | $368.0K | $536.5M | −$85.9M (−13.8%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Coherus Oncology, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 572,928 | $3.92M | 0.01% |
| Phocas Financial Corp. | 163,140 | $1.12M | 0.16% |
| Caxton Associates LP | 112,186 | $767.4K | 0.12% |
| Profund Advisors LLC | 77,101 | $527.4K | 0.03% |
| New York Life Investment Management LLC | 72,904 | $498.7K | 0.01% |
| Endurant Capital Management LP | 64,956 | $444.3K | 0.23% |
| Verition Fund Management LLC | 49,089 | $335.8K | 0.01% |
| Dynamic Technology Lab Private Ltd | 42,413 | $290.0K | 0.03% |
| Larson Financial Group LLC | 27,409 | $187.5K | 0.02% |
| SG Americas Securities, LLC | 27,124 | $186.0K | 0.00% |
| CM Wealth Advisors LLC | 19,148 | $144.0K | 0.03% |
| Quantamental Technologies LLC | 16,637 | $113.8K | 0.06% |
| Axq Capital, LP | 15,465 | $105.8K | 0.04% |
| Jump Financial, LLC | 13,926 | $95.3K | 0.00% |
| Bank of Montreal | 12,243 | $86.6K | 0.00% |
| Vident Investment Advisory, LLC | 12,197 | $83.4K | 0.00% |
| Quantbot Technologies LP | 11,400 | $78.0K | 0.01% |
| Amundi | 8,785 | $67.5K | 0.00% |
| Dark Forest Capital Management LP | 9,686 | $66.3K | 0.02% |
| Point72 Middle East FZE | 1,456 | $9.96K | 0.00% |
| Versant Capital Management, Inc | 767 | $5.25K | 0.00% |
Sold out (18)
Institutions that held Coherus Oncology, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Knott David M Jr | 128,517 | $1.02M |
| Connor, Clark & Lunn Investment Management Ltd. | 88,022 | $697.1K |
| Velan Capital Investment Management LP | 82,605 | $654.2K |
| XTX Topco Ltd | 48,756 | $386.1K |
| Man Group plc | 35,685 | $282.6K |
| STRS Ohio | 30,300 | $239.0K |
| Bayesian Capital Management, LP | 23,800 | $188.5K |
| Walleye Capital LLC | 16,467 | $130.4K |
| Virginia Retirement Systems Et Al | 16,200 | $128.3K |
| Landscape Capital Management, L.L.C. | 16,058 | $127.2K |
| Wolverine Trading, LLC | 15,299 | $121.0K |
| Alpine Global Management, LLC | 12,714 | $101.0K |
| Sargent Investment Group, LLC | 11,200 | $88.7K |
| Metropolitan Life Insurance Co | 4,249 | $33.7K |
| Sutton Wealth Advisors Inc. | 3,473 | $27.5K |
| IFP Advisors, Inc | 1,000 | $16.0K |
| Rockefeller Capital Management L.P. | 449 | $3.00K |
| Quadrant Capital Group LLC | 21 | $166 |
Not filed for Q1 2023 yet (1)
Institutions that held Coherus Oncology, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Comerica Bank | 37,892 | $368.0K |